9500 Participants Needed

5-Year vs. 10-Year Colonoscopy for Colorectal Cancer Prevention

(FORTE Trial)

Recruiting at 435 trial locations
NW
DD
Overseen ByDirector, Department of Regulatory Affairs
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: NRG Oncology
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. Please consult with the trial coordinators for guidance.

What data supports the effectiveness of the treatment 5-year and 10-Year Surveillance Colonoscopy for colorectal cancer prevention?

The research suggests that a 10-year colonoscopy after a negative result does not significantly reduce early colorectal cancer risk, indicating the need for further studies. However, surveillance colonoscopy is generally aimed at reducing cancer incidence by removing growths and detecting cancer early, especially in those with higher risk factors.12345

Is colonoscopy generally safe for humans?

Colonoscopy is generally considered safe, but like any medical procedure, it can have risks. Some studies have looked at adverse events (unwanted side effects) during long-term colonoscopy programs, but detailed safety data is limited.12567

How does the 5-year vs. 10-year colonoscopy treatment for colorectal cancer prevention differ from other treatments?

This treatment is unique because it compares the effectiveness of having a colonoscopy every 5 years versus every 10 years for preventing colorectal cancer, focusing on the timing of surveillance rather than a new drug or procedure.12347

What is the purpose of this trial?

This trial aims to determine the best schedule for preventing small, non-dangerous growths in the colon from turning into cancer by regularly checking and removing them.

Research Team

RS

Robert Schoen, MD

Principal Investigator

University of Pittsburgh

Eligibility Criteria

This trial is for people who've had a colonoscopy within the last 4 years, found to have 1-2 small non-advanced adenomas, and removed them completely. They must be able to understand English or Spanish and give informed consent. It's not for those with high genetic risk of colorectal cancer, inflammatory bowel disease, large hyperplastic polyps, previous significant cancers (except certain skin cancers), or life expectancy less than 10 years.

Inclusion Criteria

All polyps found during my colonoscopy were completely removed.
I had a thorough colonoscopy with clear views and good cleansing within the last 4 years.
I was diagnosed with 1-2 small, non-advanced tubular adenomas less than 4 years ago.
See 3 more

Exclusion Criteria

I have had surgery to remove part or all of my colon.
A close family member had colorectal cancer at 60 or older, or two relatives had it at any age.
I have had a large growth in my colon before.
See 12 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Qualifying Colonoscopy

Participants undergo a qualifying colonoscopy to identify 1-2 non-advanced adenomas

1 day
1 visit (in-person)

Surveillance Colonoscopy

Participants are randomized to undergo surveillance colonoscopy at either 5 years and 10 years or only at 10 years

10 years
2 visits (in-person) for 5-year and 10-year group, 1 visit (in-person) for 10-year group

Follow-up

Participants are monitored for incidence of advanced adenoma and colorectal cancer

10 years

Treatment Details

Interventions

  • 5-year and 10 Year Surveillance Colonoscopy after Qualifying Colonoscopy
Trial Overview The study is testing if it's just as effective to do follow-up colonoscopies at ten-year intervals instead of five after finding and removing small benign polyps. Participants are randomly placed into two groups: one will have a check-up at five years and another only at ten years.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Arm 2Experimental Treatment1 Intervention
10-Year Surveillance Colonoscopy after Qualifying Colonoscopy
Group II: Arm 1Experimental Treatment1 Intervention
5-Year and 10-Year Surveillance Colonoscopy after Qualifying Colonoscopy

5-year and 10 Year Surveillance Colonoscopy after Qualifying Colonoscopy is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Surveillance Colonoscopy for:
  • Colorectal Cancer Screening
  • Follow-up after adenomatous polyp removal
🇪🇺
Approved in European Union as Surveillance Colonoscopy for:
  • Colorectal Cancer Screening
  • Follow-up after adenomatous polyp removal

Find a Clinic Near You

Who Is Running the Clinical Trial?

NRG Oncology

Lead Sponsor

Trials
242
Recruited
105,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Findings from Research

In a study of 13,350 matched pairs of individuals aged 50-74 with a previous negative colonoscopy, undergoing a repeat colonoscopy 10 years later did not significantly reduce the risk of early incident colorectal cancer (CRC).
The cumulative probability of developing CRC was similar between those who had a repeat colonoscopy (0.70%) and those who did not (0.77%), suggesting that the current recommendation for 10-year re-screening may need further evaluation.
Risk of colorectal cancer after a negative colonoscopy in low-to-moderate risk individuals: impact of a 10-year colonoscopy.Murthy, SK., Dubé, C., Rostom, A., et al.[2018]
In a study of 3,121 asymptomatic subjects aged 50 to 75, those with baseline neoplasia had a significantly higher risk of developing advanced neoplasia within 5.5 years, with relative risks ranging from 1.92 to 6.87 depending on the type and size of adenomas found during initial screening.
Patients with 1 or 2 tubular adenomas smaller than 10 mm were identified as a low-risk group for developing serious lesions, suggesting that not all neoplasia findings carry the same risk for future complications.
Five-year colon surveillance after screening colonoscopy.Lieberman, DA., Weiss, DG., Harford, WV., et al.[2022]
Patients with nonadvanced adenomas can safely extend their postpolypectomy colonoscopy surveillance intervals beyond 5 years, as their risk of advanced adenoma recurrence is similar whether they are screened at 5 years or 6 to 10 years.
Those with an advanced adenoma at their initial colonoscopy have a significantly higher risk of finding another advanced adenoma at follow-up (26% at 5 years), indicating they should have their next colonoscopy sooner than 5 years.
Colonoscopy surveillance after polypectomy may be extended beyond five years.Miller, HL., Mukherjee, R., Tian, J., et al.[2022]

References

Risk of colorectal cancer after a negative colonoscopy in low-to-moderate risk individuals: impact of a 10-year colonoscopy. [2018]
Five-year colon surveillance after screening colonoscopy. [2022]
Colonoscopy surveillance after polypectomy may be extended beyond five years. [2022]
Baseline Colonoscopy Findings Associated With 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy Surveillance. [2020]
Surveillance after colorectal polyp removal. [2022]
Longitudinal assessment of colonoscopy adverse events in the prospective Cooperative Studies Program no. 380 colorectal cancer screening and surveillance cohort. [2023]
Outcomes after 10 years of a community-based flexible sigmoidoscopy screening program for colorectal carcinoma. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security